Skip to content
healthcare.dev
Get a free key

Pyridostigmine Bromide

NDC 47781-335, Pyridostigmine Bromide, tablet, extended release, from Alvogen, Inc..

Product NDC
47781-335
Status
Listed
Labeler
Alvogen, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204737
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-335 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE180 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
47781-335-304778103353030 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93454159-0c58-1980-34b9-4038a2260420

  • NADAC price for package 47781033530

    GET /v1/drugs/nadac/47781033530

Use it

Look up 47781-335 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-335 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-335. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.